Medical Oncology Software Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Growth Factors of Medical Oncology Software Market
The Medical Oncology Software market size was valued at USD 2.40 billion in 2023, and the market is now projected to grow from USD 2.54 billion in 2024 to USD 4.22 billion by 2032, exhibiting a CAGR of 7.5% during the forecast period of 2024-2032.
The medical oncology software market was affected in a major way by the COVID-19 pandemic. During the pandemic, oncology care was deprioritized secondary to COVID related treatments causing the oncology services to deteriorate and leading to the call for advanced technologies such as telemedicine and home monitoring for those with cancer. Telemedicine and digital health had a breakout year for medical oncology software to maintain care delivery across practices and enhance efficiencies. Also, the increase in clinical research of COVID-19 vaccines and treatment also compelled new oncology research platforms. Looking at the dynamics of the future after the pandemic, the market will experience further expansion as cancer care demands advanced, digital solutions.
In the market of medical oncology software, there are several major trends at the moment. Intelligent computing is being applied in improving diagnostic tools, custom treatment, and prognosis. Hosted products are now preferred since they afford secure, flexible access to the patient information and help to optimize processes. There has been increased use of telemedicine and remote patient monitoring in patients’ management that do not require the clinical environment. Also, there is a growing trend in sharing data in actual time across different healthcare settings to reach better coordination. These innovations are leading to more efficient and evidence based solutions to the problems facing the cancer market. Thus, all the above mentioned factors are contributing towards the medical oncology software market growth.
The following are the factors that make the medical oncology software market significant. More and more people develop cancer around the world which means that more efficient solutions of patient management are needed. Technological breakthroughs in diagnose and treatment utilizing AI, and machine learning propel the software utilization. More attention to the uses of the individual approach and precision cancer therapy also contributes to heightened interest in new opportunities. Also, the demand for efficient processes and ways to improve the availability of oncology data, as well as interfaces between the healthcare systems also are the drivers for oncology software acquisition. Others and telemedicine and remote monitoring devices, which have been adopted due to the COVID-19 outbreak, are also the growth driving forces of the mentioned market.
Comprehensive Analysis Medical Oncology Software Market
Segmenting the Medical Oncology Software market based on deployment types has its benefits: Cloud-Based Solutions, On-Premise Solutions and Hybrid Solutions. The cloud-provided solutions make it possible to work with the patient data, share it and change it in real-time; however, the on-premise products allow making data more secure and controlled. The fully integrated models utilize both approaches with enhanced flexibility to healthcare providers. Examples of use cases encompass: treatment planning, patient record management, and clinical decision support; others provide supplemental touch points for oncology. This target population consists of Hospitals and specialist clinic, diagnostic centers, research institutions and other clients in the health care sector requiring effective software for improved cancer health care.
North America stands for the largest share in the medical oncology software market due to the better health care facilities, higher incidences of cancer and focus on research and development. The concentration of large technology firms and oncology-oriented software firms promotes advanced setting and deployment of digital interventions. Moreover, there are other complementary government policies that came up in support of cancer research and finances put forward also help accentuate the market growth. Another factor also adding to the regions significance is the growing focus on precision medicine and management of patient care solutions. The listed changes in numerous healthcare systems predict that North America will sustain its dominance in the future.
Key players in this sector include Epic Systems Corporation (U.S.), Altai, Inc. (U.S.), Varian Medical Systems, Inc. (Siemens Healthineers AG) (U.S.), Cerner Corporation (Oracle) (U.S.), American Medical Software (U.S.), Elekta (Sweden), EndoSoft LLC (U.S.), RaySearch Laboratories (Sweden), MCKESSON CORPORATION (U.S.)
The emerging trends of medical oncology software of 2024 are observed mainly in the treatment planning systems. Some of these solutions are becoming integrated with Artificial Intelligence and machine learning to make them more precise in the therapy choice and in the dosage. Big data is being applied to additionally analyze tremendous quantities of data, to deliver target treatment in accordance with the patient’s characteristics. Additionally, having tele-health abilities embedded in treatment planning software enables subsequent remote consultations as well as consistent patient assessment.
Segmentation Table
ATTRIBUTE DETAILS
Study Period 2019-2030
Base Year 2022
Estimated Year 2023
Forecast Period 2023-2030
Historical Period 2019-2021
Growth Rate CAGR of 6.1% from 2023 to 2030
Unit Value (USD million)
Segmentation By Product Type, End-User, and Region
Segmentation By Product Type
Rolling Flat Dies
Thread Rolling Cylindrical Dies
Rotary Type Thread Rolling Dies
Rack Type Rolling Dies
Trimming Dies
Round Dies
Others (Drill Point Dies)
By End-User
Automotive
White Goods
Medical
Cutlery
Consumer Electronics
General Engineering
Others (Marine)
By Region
North America (By Product Type, End-User and Country)
U.S.
Canada
Europe (By Product Type, End-User and Country)
U.K.
Germany
France
Italy
Spain
Russia
BENELUX
Nordics
Rest of Europe
Asia Pacific (By Product Type, End-User and Country)
China
India
Japan
South Korea
ASEAN
Oceania
Rest of Asia Pacific
Middle East & Africa (By Product Type, End-User and Country)
Israel
Turkey
GCC
North Africa
South Africa
Rest of Middle East & Africa
South America (By Product Type, End-User and Country)
Brazil
Argentina
Rest of South America
Please Note: It will take 5-6 business days to complete the report upon order confirmation.
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
- 4. Key Insights
- 4.1. Prevalence of Cancer, by Key Countries, in 2021/2022
- 4.2. Recent Technological Advancements in Medical Oncology Software
- 4.3. New Product Launches by Market Players
- 4.4. Key Industry Developments - Mergers, Acquisitions, Partnerships
- 4.5. Impact of COVID-19 on the Market
- 5. Global Medical Oncology Software Market Analysis, Insights and Forecast, 2019-2030
- 5.1. Market Analysis, Insights and Forecast – By Deployment Type
- 5.1.1. Clouds
- 5.1.2. On-premise
- 5.1.3. Hybrid
- 5.2. Market Analysis, Insights and Forecast – By Application
- 5.2.1. Treatment Planning
- 5.2.2. Patient Record Management
- 5.2.3. Clinical Decision Support
- 5.2.4. Others
- 5.3. Market Analysis, Insights and Forecast – By End User
- 5.3.1. Hospitals & Specialty Clinics
- 5.3.2. Diagnostic Centers
- 5.3.3. Research Institutes
- 5.3.4. Others
- 5.4. Market Analysis, Insights and Forecast – By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Latin America
- 5.4.5. Middle East & Africa
- 6. North America Medical Oncology Software Market Analysis, Insights and Forecast, 2019-2030
- 6.1. Market Analysis, Insights and Forecast – By Deployment Type
- 6.1.1. Clouds
- 6.1.2. On-premise
- 6.1.3. Hybrid
- 6.2. Market Analysis, Insights and Forecast – By Application
- 6.2.1. Treatment Planning
- 6.2.2. Patient Record Management
- 6.2.3. Clinical Decision Support
- 6.2.4. Others
- 6.3. Market Analysis, Insights and Forecast – By End User
- 6.3.1. Hospitals & Specialty Clinics
- 6.3.2. Diagnostic Centers
- 6.3.3. Research Institutes
- 6.3.4. Others
- 6.4. Market Analysis, Insights and Forecast – By Country
- 6.4.1. U.S.
- 6.4.2. Canada
- 7. Europe Medical Oncology Software Market Analysis, Insights and Forecast, 2019-2030
- 7.1. Market Analysis, Insights and Forecast – By Deployment Type
- 7.1.1. Clouds
- 7.1.2. On-premise
- 7.1.3. Hybrid
- 7.2. Market Analysis, Insights and Forecast – By Application
- 7.2.1. Treatment Planning
- 7.2.2. Patient Record Management
- 7.2.3. Clinical Decision Support
- 7.2.4. Others
- 7.3. Market Analysis, Insights and Forecast – By End User
- 7.3.1. Hospitals & Specialty Clinics
- 7.3.2. Diagnostic Centers
- 7.3.3. Research Institutes
- 7.3.4. Others
- 7.4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
- 7.4.1. Germany
- 7.4.2. U.K.
- 7.4.3. France
- 7.4.4. Italy
- 7.4.5. Spain
- 7.4.6. Scandinavia
- 7.4.7. Rest of Europe
- 8. Asia Pacific Medical Oncology Software Market Analysis, Insights and Forecast, 2019-2030
- 8.1. Market Analysis, Insights and Forecast – By Deployment Type
- 8.1.1. Clouds
- 8.1.2. On-premise
- 8.1.3. Hybrid
- 8.2. Market Analysis, Insights and Forecast – By Application
- 8.2.1. Treatment Planning
- 8.2.2. Patient Record Management
- 8.2.3. Clinical Decision Support
- 8.2.4. Others
- 8.3. Market Analysis, Insights and Forecast – By End User
- 8.3.1. Hospitals & Specialty Clinics
- 8.3.2. Diagnostic Centers
- 8.3.3. Research Institutes
- 8.3.4. Others
- 8.4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
- 8.4.1. China
- 8.4.2. Japan
- 8.4.3. India
- 8.4.4. Australia
- 8.4.5. Southeast Asia
- 8.4.6. Rest of Asia Pacific
- 9. Latin America Medical Oncology Software Market Analysis, Insights and Forecast, 2019-2030
- 9.1. Market Analysis, Insights and Forecast – By Deployment Type
- 9.1.1. Clouds
- 9.1.2. On-premise
- 9.1.3. Hybrid
- 9.2. Market Analysis, Insights and Forecast – By Application
- 9.2.1. Treatment Planning
- 9.2.2. Patient Record Management
- 9.2.3. Clinical Decision Support
- 9.2.4. Others
- 9.3. Market Analysis, Insights and Forecast – By End User
- 9.3.1. Hospitals & Specialty Clinics
- 9.3.2. Diagnostic Centers
- 9.3.3. Research Institutes
- 9.3.4. Others
- 9.4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
- 9.4.1. Brazil
- 9.4.2. Mexico
- 9.4.3. Rest of Latin America
- 10. Middle East & Africa Medical Oncology Software Market Analysis, Insights and Forecast, 2019-2030
- 10.1. Market Analysis, Insights and Forecast – By Deployment Type
- 10.1.1. Clouds
- 10.1.2. On-premise
- 10.1.3. Hybrid
- 10.2. Market Analysis, Insights and Forecast – By Application
- 10.2.1. Treatment Planning
- 10.2.2. Patient Record Management
- 10.2.3. Clinical Decision Support
- 10.2.4. Others
- 10.3. Market Analysis, Insights and Forecast – By End User
- 10.3.1. Hospitals & Specialty Clinics
- 10.3.2. Diagnostic Centers
- 10.3.3. Research Institutes
- 10.3.4. Others
- 10.4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
- 10.4.1. GCC
- 10.4.2. South Africa
- 10.4.3. Rest of Middle East & Africa
- 11. Competitive Analysis
- 11.1. Global Market Share Analysis (2022)
- 11.2. Company Profiles
- 11.2.1. Epic Systems Corporation
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Strategies
- 11.2.1.6. Financials (Based on Availability)
- 11.2.2. Altai, Inc.
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Strategies
- 11.2.2.6. Financials (Based on Availability)
- 11.2.3. Varian Medical Systems, Inc. (Siemens Healthineers AG)
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Strategies
- 11.2.3.6. Financials (Based on Availability)
- 11.2.4. Cerner Corporation (Oracle)
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Strategies
- 11.2.4.6. Financials (Based on Availability)
- 11.2.5. American Medical Software
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Strategies
- 11.2.5.6. Financials (Based on Availability)
- 11.2.6. Elekta
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Strategies
- 11.2.6.6. Financials (Based on Availability)
- 11.2.7. EndoSoft LLC
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Strategies
- 11.2.7.6. Financials (Based on Availability)
- 11.2.8. RaySearch Laboratories
- 11.2.8.1. Overview
- 11.2.8.2. Products
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Strategies
- 11.2.8.6. Financials (Based on Availability)
- 11.2.9. MCKESSON CORPORATION
- 11.2.9.1. Overview
- 11.2.9.2. Products
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Strategies
- 11.2.9.6. Financials (Based on Availability)
- 11.2.10. Koninklijke Philips N.V.
- 11.2.10.1. Overview
- 11.2.10.2. Products
- 11.2.10.3. SWOT Analysis
- 11.2.10.4. Recent Developments
- 11.2.10.5. Strategies
- 11.2.10.6. Financials (Based on Availability)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook